India, Oct. 31 -- What are the current challenges faced by the bulk drug manufacturers in India? Bulk drug manufacturers in India face several challenges, including constantly evolving domestic and i... Read More
India, Oct. 31 -- What are your key investment strategies for the Indian market? We have announced a strategic investment of Rs 350 crore over the next three years to expand its operations in India, ... Read More
India, Oct. 31 -- You recently presented data on Minicircle-based CAR-T cells at the CAR-TCR Summit in Boston. What makes Minicircles such a breakthrough for gene and cell therapy? Minicircles repres... Read More
Dhaka, Oct. 31 -- During the course of the last decade, a revolution has swept across Bangladesh. It did not happen through ballots or barricades, but on the screens glowing in the palms of ordinary p... Read More
Dhaka, Oct. 31 -- The struggle for the future in Bangladesh, as elsewhere in the world, reminds me of vanished times that keep reinventing themselves. The struggle makes me think of an earlier me. It... Read More
Dhaka, Oct. 31 -- Following a nearly 9 month-process of discussion and deliberation under the banner of the National Consensus Commission, most of which was broadcast live on national television, the ... Read More
Dhaka, Oct. 31 -- There was a time when snacks were not thought to be worth anyone's serious attention. That was some time ago though when Dhaka was barely an urban pimple growing on the face of the n... Read More
India, Oct. 31 -- image credit- shutterstock German firm Siegwerkhas announced its strategic entry into the pharmaceutical packaging segment in India, reinforcing its commitment to consumer safety. ... Read More
India, Oct. 31 -- Pluro Fertility and IVF, a healthcare partnership platform, has raised Rs 125 crore in Series A funding round led by Bessemer Venture Partners at a valuation of Rs 1,000 crore. The ... Read More
India, Oct. 31 -- image credit- shutterstock The US Food and Drug Administration (FDA) has announced significant action to make it faster and less costly to develop biosimilar medicines, which are lo... Read More